CYTOMEGALOVIRUS-BASED IMMUNOGENIC PREPARATIONS
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
N/A
app pub date -
Apr 19, 2016
filing date -
Jan 27, 2010
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
Methods of using recombinant replication-deficient cytomegalovirus (CMV) to generate a long-term, repeatedly stimulated immune response in a subject, for instance against a heterologous antigen expressed by the cytomegalovirus, are described. Also described are methods of using a recombinant replication deficient CMV as an anti-cancer immunogenic preparation.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully